Blood Test and Lung Nodule Treatment Request More Information Trial Objective Researchers want to know if results of a new blood test, called the Nodify XL2 test, will impact how a physician treats a patient with lung nodules. Study participants will have blood drawn. The blood sample will be analyzed using the Nodify XL2 test. The results of the Nodify XL2 test may help physicians reduce the need for biopsies or invasive procedures on a patient’s lung nodules. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate People who are over 40 with newly identified solid lung nodules that are determined to be low to moderate risk of becoming cancerous. Age: 40+ Gender: Any Gender Estimated Time Commitment Up to 2 years, with a total of 5 clinic visits Trial Contact For more information, contact: Jami Henriksen 303.398.1233 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors Biodesix, Inc. Principal Investigators Ellen Volker, MD, MSPH + × Ellen Volker, MD, MSPH Associate Professor Director, Interventional Pulmonology Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Co-Investigators Kristen Glisinski, MD + × Kristen Glisinski, MD Assistant Professor Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective Researchers want to know if results of a new blood test, called the Nodify XL2 test, will impact how a physician treats a patient with lung nodules. Study participants will have blood drawn. The blood sample will be analyzed using the Nodify XL2 test. The results of the Nodify XL2 test may help physicians reduce the need for biopsies or invasive procedures on a patient’s lung nodules.